Basis of Presentation (Tables)

3 Months Ended

Dec. 31, 2014

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Deferred Revenue, by Arrangement, Disclosure

The components of deferred profit are as follows:

	December 31, 2014		September 30, 2014
	(dollars in thousands)
Deferred revenues	$	8,354	$	8,118
Deferred costs	2,927		1,210
Deferred profit	$	5,427	$	6,908

Schedule of Inventory, Current

The components of inventories are as follows:

	December 31, 2014		September 30, 2014
	(dollars in thousands)
Purchased parts and raw materials	$	8,148	$	8,797
Work-in-process	4,988		4,809
Finished goods	5,781		3,154
	$	18,917	$	16,760

Property, Plant and Equipment

The following is a summary of property, plant and equipment:

	December 31, 2014			September 30, 2014
	(dollars in thousands)
Land, building and leasehold improvements	$	10,053		$	10,414
Equipment and machinery	9,260			8,189
Furniture and fixtures	5,310			5,453
	24,623			24,056
Accumulated depreciation and amortization	(14,363		)	(14,304		)
	$	10,260		$	9,752

Schedule of Goodwill

The following is a summary of activity in goodwill:

	Solar and Semiconductor Equipment			Polishing Supplies and Equipment		Total
	(dollars in thousands)
Balance at the beginning of year
Goodwill	$	12,315		$	728	$	13,043
Accumulated impairment losses	(4,720		)	—		(4,720		)
	7,595			728		8,323
Net exchange differences	(100		)	—		(100		)
Balance at the end of quarter
Goodwill	12,154			728		12,882
Accumulated impairment losses	(4,659		)	—		(4,659		)
	$	7,495		$	728	$	8,223

Schedule of Finite-Lived Intangible Assets

The following is a summary of intangibles:

	Useful Life	Gross Carrying Amount		Accumulated Amortization			Net Carrying Amount		Gross Carrying Amount		Accumulated Amortization			Net Carrying Amount
		December 31, 2014							September 30, 2014
		(dollars in thousands)
Non-compete agreements	4-8 years	$	1,048	$	(1,013	)	$	35	$	1,055	$	(955	)	$	100
Customer lists	10 years	783		(595		)	188		817		(592		)	225
Technology	5-10 years	2,252		(1,721		)	531		2,319		(1,682		)	637
In-process research and development	5 years	1,600		(107		)	1,493		1,600		(27		)	1,573
Other	2-10 years	5,294		(185		)	5,109		321		(178		)	143
		$	10,977	$	(3,621	)	$	7,356	$	6,112	$	(3,434	)	$	2,678

Schedule of Product Warranty Liability

The following is a summary of activity in accrued warranty expense:

	Three Months Ended December 31,
	2014			2013
	(dollars in thousands)
Beginning balance	$	628		$	1,454
Warranty expenditures	(228		)	(277		)
Warranty provisions/(adjustment)	307			(112		)
Ending balance	$	707		$	1,065

Effects of share-based compensation expense

Share-based compensation expense reduced the Company’s results of operations by the following amounts:

	Three Months Ended December 31,
	2014			2013
	(dollars in thousands)
Effect on income before income taxes (1)	$	(232	)	$	(176	)
Effect on income taxes	36			40
Effect on net income	$	(196	)	$	(136	)

(1) Stock-based compensation expense is included in selling, general and administrative expenses.

Schedule of Share-based Compensation, Stock Options, Activity

Stock option transactions and the options outstanding are summarized as follows:

	Three Months Ended December 31,
	2014				2013
	Options		Weighted Average Exercise Price		Options			Weighted Average Exercise Price
Outstanding at beginning of period	1,063,324		$	7.37	1,059,417			$	6.71
Granted	282,500		9.98		220,000			7.01
Exercised	—		—		(2,230		)	3.82
Forfeited	—		—		(2,114		)	8.03
Outstanding at end of period	1,345,824		$	7.91	1,275,073			$	6.76
Exercisable at end of period	802,703		$	7.81	924,593			$	7.04
Weighted average fair value of options granted during the period	$	6.09			$	4.38

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions

The fair value of options was estimated at the grant date using the Black-Scholes option pricing model with the following assumptions:

	Three Months Ended December 31,
	2014	2013
Risk free interest rate	2%	2%
Expected life	6 years	6 years
Dividend rate	0%	0%
Volatility	67%	69%

Schedule of Share-based Compensation, Restricted Stock Activity

Restricted stock transactions and awards outstanding are summarized as follows:

	Three Months Ended December 31,
	2014				2013
	Awards		Weighted Average Grant Date Fair Value		Awards		Weighted Average Grant Date Fair Value
Beginning Outstanding	35,203		$	10.13	69,154		$	10.13
Released	(21,663	)	11.47		(30,828	)	10.08
Forfeited	—		—		—		—
Ending Outstanding	13,540		$	7.98	38,326		$	10.17

Research and Development Expense

The table below shows gross research and development expenses and grants earned:

	Three Months Ended
	December 31, 2014			December 31, 2013
	(dollars in thousands)
Research and development	$	2,573		$	2,895
Grants earned	(736		)	(2,006		)
Net research and development	$	1,837		$	889